TCW Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.12M | Sell |
|
|||||
|
2020
Q4 | $60.2M | Buy |
|
|||||
|
2020
Q3 | $52M | Sell |
|
|||||
|
2020
Q2 | $86.1M | Sell |
|
|||||
|
2020
Q1 | $62.4M | Sell |
|
|||||
|
2019
Q4 | $62.6M | Sell |
|
|||||
|
2019
Q3 | $52.1M | Sell |
|
|||||
|
2019
Q2 | $66.7M | Sell |
|
|||||
|
2019
Q1 | $70M | Sell |
|
|||||
|
2018
Q4 | $67.3M | Sell |
|
|||||
|
2018
Q3 | $83.3M | Sell |
|
|||||
|
2018
Q2 | $81.3M | Sell |
|
|||||
|
2018
Q1 | $73.7M | Sell |
|
|||||
|
2017
Q4 | $89.3M | Sell |
|
|||||
|
2017
Q3 | $99.9M | Buy |
|
|||||
|
2017
Q2 | $81.1M | Sell |
|
|||||
|
2017
Q1 | $80M | Sell |
|
|||||
|
2016
Q4 | $90.6M | Sell |
|
|||||
|
2016
Q3 | $106M | Sell |
|
|||||
|
2016
Q2 | $93.4M | Buy |
|
|||||
|
2016
Q1 | $97.2M | Sell |
|
|||||
|
2015
Q4 | $125M | Buy |
|
|||||
|
2015
Q3 | $102M | Sell |
|
|||||
|
2015
Q2 | $148M | Sell |
|
|||||
|
2015
Q1 | $194M | Sell |
|
|||||
|
2014
Q4 | $222M | Buy |
|
|||||
|
2014
Q3 | $161M | Buy |
|
|||||
|
2014
Q2 | $134M | Sell |
|
|||||
|
2014
Q1 | $161M | Sell |
|
|||||
|
2013
Q4 | $169M | Sell |
|
|||||
|
2013
Q3 | $176M | Buy |
|
|||||
|
2013
Q2 | $128M | Buy |
|